Self-directed learning
Receptor-mediated drug action
Most clinically useful drugs act by binding to molecular targets. These targets include receptors, enzymes, ion channels, transporters, and structural proteins.
For receptor-mediated action, the key terms are affinity, intrinsic activity, efficacy, potency, selectivity, and reversibility. An agonist binds and activates a receptor response. An antagonist binds without activating the receptor and reduces the effect of an agonist.
Clinical reasoning starts by asking: What is the target? What normal signal does the target control? What happens when the drug increases, decreases, or blocks that signal?
Which pair of properties best distinguishes an agonist from a pure antagonist?
- Affinity and intrinsic activity Correct. Both bind receptors, but an agonist has intrinsic activity while a pure antagonist does not.
- Absorption and distribution These are pharmacokinetic properties, not receptor activation properties.
- Half-life and clearance These affect duration and exposure, not whether a receptor is activated.
Non-receptor and physical mechanisms
Not every drug effect depends on a classical receptor. Some drugs act by enzyme inhibition, ion channel blockade, transporter modulation, osmotic action, chemical neutralisation, or physical adsorption.
Mechanism-based grouping is more useful than memorising isolated examples. Enzyme inhibitors alter product formation. Ion channel blockers alter excitability. Osmotic agents move water. Antacids neutralise acid chemically.
A strong explanation connects mechanism to clinical effect: if a drug inhibits cyclooxygenase, prostaglandin synthesis falls, so inflammation and pain can fall but gastric protection may also fall.
Which option is the best example of a non-receptor physical or chemical mechanism?
- Activated charcoal adsorbing a toxin in the gut Correct. Adsorption is a physical mechanism rather than receptor activation.
- Salbutamol activating beta-2 receptors That is receptor-mediated agonism.
- Naloxone blocking opioid receptors That is receptor antagonism.
Mechanism-based clinical reasoning
Mechanism of action is clinically useful because it supports prediction. A drug that increases a physiological pathway can produce both desired and unwanted effects through the same pathway.
Dose-response reasoning matters. A competitive antagonist often shifts an agonist concentration-response curve to the right. A non-competitive antagonist or irreversible blocker can reduce the maximal effect.
Mechanism also helps interpret combinations. Two drugs acting at different steps of the same pathway may produce additive benefit or toxicity. Learners should explicitly state the target, direction of effect, clinical outcome, and predictable harm.
What is expected with a reversible competitive antagonist in a simple agonist dose-response experiment?
- A rightward shift that can be overcome by more agonist Correct. The antagonist competes at the receptor, so higher agonist concentration can restore response.
- A permanent fall in maximum response in every case That is more typical of non-competitive or irreversible antagonism.
- No change in the response curve Competitive antagonism changes apparent potency.